
Dirk Schadendorf, MD, University Hospital Essen
Advertisement
Articles by Dirk Schadendorf, MD, University Hospital Essen
Advertisement
Latest Updated Articles
Molecular Testing in Metastatic MelanomaJanuary 22nd 2021
The Role of COVID-19 in Adjuvant Treatment Decisions in MelanomaJanuary 22nd 2021
Looking at Approved Agents in Metastatic MelanomaJanuary 29th 2021
Testing and BRAF Mutations in MelanomaJanuary 8th 2021
Future Directions in Metastatic MelanomaFebruary 5th 2021
A Look at the KEYNOTE-054 and COMBI-AD DataJanuary 15th 2021
Advertisement
Advertisement
Trending on OncLive
1
FDA Removes Limitations of Use for Liso-Cel in Primary Central Nervous System Lymphoma
2
FDA Accepts sNDA for Selinexor Plus Ruxolitinib in Myelofibrosis
3
Beyond the Target: Payloads, Therapeutic Windows, and Biomarkers Shape the Next Wave of ADCs in NSCLC
4
Sintilimab Receives Positive CHMP Opinion for First-Line Nonsquamous NSCLC
5








